{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:35:00Z","timestamp":1786707300672,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-COVID syndrome (PCS) refers to persistent or new-onset symptoms 3 months after SARS-CoV-2 infection lasting for at least 2 months. The characterization of PCS varies across studies, with a substantial heterogeneity regarding different study samples, survey instruments, and follow-up periods. This is particularly the case in hospitalized patients vs. outpatients, as well as regarding different variants of concern (VOCs) and their impact on the frequency and severity of specific symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study population of\n                      <jats:italic>Beyond COVID<\/jats:italic>\n                      was recruited in six German cities by inviting (1) individuals registered as SARS-CoV-2 PCR positive at the local Public Health Authorities and (2) previously hospitalized patients with infection date after 1st March 2021. Participants were allocated to the predominant VOC of their first infection. Questionnaires to assess pre-existing conditions, symptoms during infection, and persisting symptomswere performed. Follow-up at sixth-month intervals is planned for 3\u00a0years. The study is ongoing. This publication describes the parameters at the baseline visit (BV).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 1257 participants (13% hospitalized-based; 87% population-based). Most participants had BA.2 (n\u2009=\u2009436; 35%), followed by Delta (n\u2009=\u2009336; 27%), BA.1 (n\u2009=\u2009238; 19%), and Alpha (n\u2009=\u2009218; 17%). The mean age was 47.1\u00a0years, and 59% of the participants were female. 72% reported at least one persisting symptom. Fatigue was the most frequent ongoing symptom (33%), followed by concentration disorders (25%) and dyspnoea (22%). Female sex, lower education, and a shorter period between infection and BV were associated with higher rates of persisting symptoms and symptom severity. Among all VOCs, participants with BA.1 and BA.2 had the lowest rates of persisting symptoms and symptom severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Analysis of baseline data from the Beyond-COVID cohort confirms a high percentage of persistent symptoms. Omicron variants had lower rates of persistent symptoms and symptom severity. We are confident, that long-term follow-up and the additional results from our clinical examinations, blood samples, sociodemographic and psychosocial data will further contribute to the characterization of PCS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-026-02819-6","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:21:18Z","timestamp":1779096078000},"page":"1953-1968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany"],"prefix":"10.1007","volume":"54","author":[{"given":"Alexander","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"Bergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Breitschwerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Pracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Killer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Kuklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schwichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siona","family":"B\u00fchrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zeissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil-Robin","family":"Tepasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f6rge","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Dragano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn-Erik-Ole","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Beyond COVID Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Gliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Fla\u00dfhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Vollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarethe","family":"Konik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"F\u00fcnger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Malin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Sovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2819_CR1","unstructured":"WHO. WHO COVID-19 dashboard 2026. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=o."},{"key":"2819_CR2","unstructured":"WHO. Post COVID-19 condition (Long COVID) 2022. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"key":"2819_CR3","unstructured":"COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence: Clinical Guidelines. London; 2024."},{"issue":"1","key":"2819_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00406-024-01868-y","volume":"275","author":"J Gutzeit","year":"2025","unstructured":"Gutzeit J, Weiss M, Nurnberger C, Lemhofer C, Appel KS, Pracht E, et al. Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella review. Eur Arch Psychiatry Clin Neurosci. 2025;275(1):129\u201340.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"21","key":"2819_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1055\/a-1940-1222","volume":"147","author":"C Lemhofer","year":"2022","unstructured":"Lemhofer C, Appel KS, Hauser W, Hettich N, Kohls M, Polidori MC. Post COVID\u2014just a matter of definition? Dtsch Med Wochenschr. 2022;147(21):1391\u20137.","journal-title":"Dtsch Med Wochenschr"},{"key":"2819_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.750378","volume":"8","author":"LD Hayes","year":"2021","unstructured":"Hayes LD, Ingram J, Sculthorpe NF. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Front Med (Lausanne). 2021;8:750378.","journal-title":"Front Med (Lausanne)"},{"key":"2819_CR7","doi-asserted-by":"crossref","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021.","DOI":"10.21203\/rs.3.rs-266574\/v1"},{"issue":"9","key":"2819_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593\u2013607.","journal-title":"J Infect Dis"},{"key":"2819_CR9","doi-asserted-by":"publisher","first-page":"1604501","DOI":"10.3389\/phrs.2022.1604501","volume":"43","author":"V Nittas","year":"2022","unstructured":"Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. Long COVID Through a Public Health Lens: An Umbrella Review. Public Health Rev. 2022;43:1604501.","journal-title":"Public Health Rev"},{"key":"2819_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejim.2021.06.009","volume":"92","author":"C Fernandez-de-Las-Penas","year":"2021","unstructured":"Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021;92:55\u201370.","journal-title":"Eur J Intern Med"},{"issue":"16","key":"2819_CR11","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"S Wulf Hanson","year":"2022","unstructured":"Global Burden of Disease Long CC, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604\u201315.","journal-title":"JAMA"},{"issue":"7","key":"2819_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cid\/ciab611","volume":"74","author":"J Seessle","year":"2022","unstructured":"Seessle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191\u20138.","journal-title":"Clin Infect Dis"},{"key":"2819_CR13","doi-asserted-by":"crossref","unstructured":"Vishwakarma N, Goud RB, Tirupattur MP, Katwa LC. The eye of the storm: investigating the long-term cardiovascular effects of COVID-19 and variants. Cells. 2023;12(17).","DOI":"10.3390\/cells12172154"},{"key":"2819_CR14","doi-asserted-by":"crossref","unstructured":"Sarkar M, Madabhavi I. SARS-CoV-2 variants of concern: a review. Monaldi Arch Chest Dis. 2022;93(3).","DOI":"10.4081\/monaldi.2022.2337"},{"key":"2819_CR15","unstructured":"Koch-Institute R. SARS-CoV-2 variants in Germany 2026. https:\/\/public.data.rki.de\/t\/public\/views\/IGS_Dashboard\/DashboardVOC?%3Aembed=y&%3AisGuestRedirectFromVizportal=y."},{"issue":"1","key":"2819_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07414-x","volume":"12","author":"A Perez-Gonzalez","year":"2022","unstructured":"Perez-Gonzalez A, Araujo-Ameijeiras A, Fernandez-Villar A, Crespo M, Poveda E, Cohort C-otGSHRI. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. 2022;12(1):3369.","journal-title":"Sci Rep"},{"key":"2819_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2025.105833","volume":"180","author":"N Brazer","year":"2025","unstructured":"Brazer N, Servellita V, Jin C, Foresythe A, Oseguera M, Nguyen J, et al. Differential severity of SARS-CoV-2 variant infections in children and adults with COVID-19. J Clin Virol. 2025;180:105833.","journal-title":"J Clin Virol"},{"issue":"10343","key":"2819_CR18","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263\u20134.","journal-title":"Lancet"},{"key":"2819_CR19","doi-asserted-by":"crossref","unstructured":"Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 Caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(23).","DOI":"10.3390\/ijerph192316010"},{"issue":"2","key":"2819_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamainternmed.2021.7949","volume":"182","author":"AA Butt","year":"2022","unstructured":"Butt AA, Dargham SR, Chemaitelly H, Al Khal A, Tang P, Hasan MR, et al. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar. JAMA Intern Med. 2022;182(2):197\u2013205.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2819_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJMoa2116597","volume":"386","author":"DW Eyre","year":"2022","unstructured":"Eyre DW, Taylor D, Purver M, Chapman D, Fowler T, Pouwels KB, et al. Effect of Covid-19 vaccination on transmission of Alpha and Delta variants. N Engl J Med. 2022;386(8):744\u201356.","journal-title":"N Engl J Med"},{"issue":"2","key":"2819_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00008-22","volume":"10","author":"C Trobajo-Sanmartin","year":"2022","unstructured":"Trobajo-Sanmartin C, Martinez-Baz I, Miqueleiz A, Fernandez-Huerta M, Burgui C, Casado I, et al. Differences in transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) variants. Microbiol Spectr. 2022;10(2):e0000822.","journal-title":"Microbiol Spectr."},{"issue":"7","key":"2819_CR23","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/S2214-109X(22)00114-0","volume":"10","author":"W Jassat","year":"2022","unstructured":"Jassat W, Abdool Karim SS, Mudara C, Welch R, Ozougwu L, Groome MJ, et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Health. 2022;10(7):e961\u20139.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"2819_CR24","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s15010-024-02270-5","volume":"52","author":"SM Putz","year":"2024","unstructured":"Putz SM, Appel KS, Miljukov O, Schneider J, Addo MM, Bals R, et al. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP). Infection. 2024;52(6):2253\u201367.","journal-title":"Infection"},{"issue":"8","key":"2819_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10654-022-00896-z","volume":"37","author":"M Schons","year":"2022","unstructured":"Schons M, Pilgram L, Reese JP, Stecher M, Anton G, Appel KS, et al. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37(8):849\u201370.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"2819_CR26","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1016\/S2589-7500(23)00056-0","volume":"5","author":"LS Canas","year":"2023","unstructured":"Canas LS, Molteni E, Deng J, Sudre CH, Murray B, Kerfoot E, et al. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit Health. 2023;5(7):e421\u201334.","journal-title":"Lancet Digit Health"},{"key":"2819_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102107","volume":"62","author":"E Gentilotti","year":"2023","unstructured":"Gentilotti E, Gorska A, Tami A, Gusinow R, Mirandola M, Rodriguez Bano J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"2819_CR28","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1111\/jdv.17045","volume":"35","author":"OM Moreno-Arrones","year":"2021","unstructured":"Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, Arias-Santiago S, Saceda-Corralo D, Bernardez-Guerra C, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021;35(3):e181\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2819_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/07853890.2022.2054026","volume":"54","author":"G Guarnieri","year":"2022","unstructured":"Guarnieri G, Bertagna De Marchi L, Marcon A, Panunzi S, Batani V, Caminati M, et al. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia. Ann Med. 2022;54(1):869\u201374.","journal-title":"Ann Med"},{"key":"2819_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdin.2022.02.006","volume":"7","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Tosti A. Alopecia in patients with COVID-19: A systematic review and meta-analysis. JAAD Int. 2022;7:67\u201377.","journal-title":"JAAD Int"},{"key":"2819_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1011936","volume":"10","author":"RN Low","year":"2023","unstructured":"Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne). 2023;10:1011936.","journal-title":"Front Med (Lausanne)"},{"key":"2819_CR32","first-page":"3","volume":"38","author":"KLA Tolksdorf","year":"2022","unstructured":"Tolksdorf KLA, Buda S. Dritte Aktualisierung der \u201eRetrospektiven Phaseneinteilung der COVID-19-Pandemie in Deutschland\u201c. Epid Bull. 2022;38:3\u20136.","journal-title":"Epid Bull."},{"key":"2819_CR33","doi-asserted-by":"crossref","unstructured":"Merzon E, Weiss M, Krone B, Cohen S, Ilani G, Vinker S, Cohen-Golan A, Green I, Israel A, Schneider T, Ashkenazi S, Weizman A, Manor I. Clinical and socio-demographic variables associated with the diagnosis of long COVID syndrome in youth: a population-based study. Int J Environ Res Public Health. 2022;19(10).","DOI":"10.3390\/ijerph19105993"},{"key":"2819_CR34","doi-asserted-by":"publisher","first-page":"745758","DOI":"10.3389\/fcvm.2021.745758","volume":"8","author":"S Charfeddine","year":"2021","unstructured":"Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:745758.","journal-title":"Front Cardiovasc Med."},{"issue":"2","key":"2819_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210\u20136.","journal-title":"Nat Immunol"},{"issue":"1","key":"2819_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jim-2021-002051","volume":"70","author":"P Glynne","year":"2022","unstructured":"Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70(1):61\u20137.","journal-title":"J Investig Med"},{"issue":"7985","key":"2819_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139\u201348.","journal-title":"Nature"},{"issue":"5","key":"2819_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881\u20139520.","journal-title":"Cell"},{"issue":"6","key":"2819_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.resinv.2023.08.008","volume":"61","author":"H Terai","year":"2023","unstructured":"Terai H, Ishii M, Takemura R, Namkoong H, Shimamoto K, Masaki K, et al. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study. Respir Investig. 2023;61(6):802\u201314.","journal-title":"Respir Investig"},{"issue":"4","key":"2819_CR40","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"2819_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271310","volume":"17","author":"JI Silverberg","year":"2022","unstructured":"Silverberg JI, Zyskind I, Naiditch H, Zimmerman J, Glatt AE, Pinter A, et al. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults. PLoS ONE. 2022;17(8):e0271310.","journal-title":"PLoS ONE"},{"issue":"4","key":"2819_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.104673","volume":"53","author":"A Perisse","year":"2023","unstructured":"Perisse A, De Cacqueray F, Delarbre D, Marsaa H, Bergmann C, Da Silva V, et al. Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier. Infect Dis Now. 2023;53(4):104673.","journal-title":"Infect Dis Now"},{"issue":"10302","key":"2819_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","volume":"398","author":"L Huang","year":"2021","unstructured":"Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747\u201358.","journal-title":"Lancet"},{"issue":"7","key":"2819_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac270","volume":"9","author":"G Helmsdal","year":"2022","unstructured":"Helmsdal G, Hanusson KD, Kristiansen MF, Foldbo BM, Danielsen ME, Steig BA, et al. Long COVID in the long run-23-month follow-up study of persistent symptoms. Open Forum Infect Dis. 2022;9(7):ofac270.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"2819_CR45","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s15010-023-02043-6","volume":"51","author":"Y Shi","year":"2023","unstructured":"Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, et al. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM\/NAPKON-POP cohort. Infection. 2023;51(6):1679\u201394.","journal-title":"Infection"},{"issue":"6","key":"2819_CR46","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamainternmed.2023.0750","volume":"183","author":"V Tsampasian","year":"2023","unstructured":"Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566\u201380.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"2819_CR47","volume":"14","author":"AS Menezes Jr","year":"2022","unstructured":"Menezes AS Jr, Botelho SM, Santos LR, Rezende AL. Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study. Cureus. 2022;14(10):e29826.","journal-title":"Cureus"},{"issue":"1","key":"2819_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36142","volume":"4","author":"M Bellan","year":"2021","unstructured":"Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142.","journal-title":"JAMA Netw Open"},{"key":"2819_CR49","unstructured":"BMG TFMoH. Current vaccination status. 2023."},{"issue":"3","key":"2819_CR50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/ssqu.13147","volume":"103","author":"F Viskupic","year":"2022","unstructured":"Viskupic F, Wiltse DL, Meyer BA. Trust in physicians and trust in government predict COVID-19 vaccine uptake. Soc Sci Q. 2022;103(3):509\u201320.","journal-title":"Soc Sci Q"},{"issue":"6","key":"2819_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048172","volume":"11","author":"MF Lindholt","year":"2021","unstructured":"Lindholt MF, Jorgensen F, Bor A, Petersen MB. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021;11(6):e048172.","journal-title":"BMJ Open"},{"issue":"1","key":"2819_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05250-4","volume":"22","author":"S Sethi","year":"2021","unstructured":"Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW, et al. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials. 2021;22(1):296.","journal-title":"Trials"},{"key":"2819_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1112383","volume":"11","author":"N Yuan","year":"2023","unstructured":"Yuan N, Lv ZH, Sun CR, Wen YY, Tao TY, Qian D, et al. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Front Public Health. 2023;11:1112383.","journal-title":"Front Public Health"},{"issue":"9","key":"2819_CR54","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","volume":"27","author":"B Blomberg","year":"2021","unstructured":"Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607\u201313.","journal-title":"Nat Med"},{"key":"2819_CR55","doi-asserted-by":"crossref","unstructured":"Fernandez-de-Las-Penas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L, Torres-Macho J, Plaza-Manzano G. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14(12).","DOI":"10.3390\/v14122629"},{"issue":"2","key":"2819_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281429","volume":"18","author":"T Ballouz","year":"2023","unstructured":"Ballouz T, Menges D, Kaufmann M, Amati R, Frei A, von Wyl V, et al. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: pooled analysis of two population-based cohorts. PLoS ONE. 2023;18(2):e0281429.","journal-title":"PLoS ONE"},{"issue":"5","key":"2819_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.104688","volume":"53","author":"A Hernandez-Aceituno","year":"2023","unstructured":"Hernandez-Aceituno A, Garcia-Hernandez A, Larumbe-Zabala E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect Dis Now. 2023;53(5):104688.","journal-title":"Infect Dis Now"},{"issue":"1","key":"2819_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35240-2","volume":"13","author":"K Magnusson","year":"2022","unstructured":"Magnusson K, Kristoffersen DT, Dell\u2019Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, et al. Post-COVID medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13(1):7363.","journal-title":"Nat Commun"},{"issue":"4","key":"2819_CR59","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jinf.2021.08.027","volume":"83","author":"E Teyssou","year":"2021","unstructured":"Teyssou E, Delagreverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, et al. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021;83(4):e1\u20133.","journal-title":"J Infect"},{"issue":"10317","key":"2819_CR60","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126\u20138.","journal-title":"Lancet"},{"issue":"4","key":"2819_CR61","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jmv.27479","volume":"94","author":"C Tani-Sassa","year":"2022","unstructured":"Tani-Sassa C, Iwasaki Y, Ichimura N, Nagano K, Takatsuki Y, Yuasa S, et al. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo. J Med Virol. 2022;94(4):1707\u201310.","journal-title":"J Med Virol"},{"key":"2819_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","volume":"136","author":"S Diexer","year":"2023","unstructured":"Diexer S, Klee B, Gottschick C, Xu C, Broda A, Purschke O, et al. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int J Infect Dis. 2023;136:14\u201321.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"2819_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/jwh.2020.8721","volume":"30","author":"J Ancochea","year":"2021","unstructured":"Ancochea J, Izquierdo JL, Soriano JB. Evidence of gender differences in the diagnosis and management of Coronavirus Disease 2019 patients: an analysis of electronic health records using natural language processing and machine learning. J Womens Health (Larchmt). 2021;30(3):393\u2013404.","journal-title":"J Womens Health (Larchmt)"},{"issue":"7","key":"2819_CR64","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"2819_CR65","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934\u201346.","journal-title":"JAMA"},{"key":"2819_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192416841","author":"NH Goldhaber","year":"2022","unstructured":"Goldhaber NH, Kohn JN, Ogan WS, Sitapati A, Longhurst CA, Wang A, et al. Deep dive into the long haul: Analysis of symptom clusters and risk factors for post-acute sequelae of COVID-19 to inform clinical care. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph192416841.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"2819_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102449","volume":"6","author":"S Shahbaz","year":"2025","unstructured":"Shahbaz S, Osman M, Syed H, Mason A, Rosychuk RJ, Cohen Tervaert JW, et al. Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME\/CFS. Cell Rep Med. 2025;6(11):102449.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2819_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1468-2","volume":"19","author":"EM Lacerda","year":"2019","unstructured":"Lacerda EM, Geraghty K, Kingdon CC, Palla L, Nacul L. A logistic regression analysis of risk factors in ME\/CFS pathogenesis. BMC Neurol. 2019;19(1):275.","journal-title":"BMC Neurol"},{"issue":"4","key":"2819_CR69","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000540919","volume":"59","author":"A Gorenshtein","year":"2025","unstructured":"Gorenshtein A, Leibovitch L, Liba T, Stern S, Stern Y. Gender disparities in neurological symptoms of long COVID: A systematic review and meta-analysis. Neuroepidemiology. 2025;59(4):426\u201340.","journal-title":"Neuroepidemiology"},{"key":"2819_CR70","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.17041.1","volume":"6","author":"A Fernandez-Sanles","year":"2021","unstructured":"Fernandez-Sanles A, Smith D, Clayton GL, Northstone K, Carter AR, Millard LA, et al. Bias from questionnaire invitation and response in COVID-19 research: An example using ALSPAC. Wellcome Open Res. 2021;6:184.","journal-title":"Wellcome Open Res"},{"issue":"1","key":"2819_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25908-6","volume":"13","author":"AR Guedes","year":"2023","unstructured":"Guedes AR, Oliveira MS, Tavares BM, Luna-Muschi A, Lazari CDS, Montal AC, et al. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic. Sci Rep. 2023;13(1):712.","journal-title":"Sci Rep"},{"issue":"8","key":"2819_CR72","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25320","volume":"5","author":"E Eythorsson","year":"2022","unstructured":"Eythorsson E, Runolfsdottir HL, Ingvarsson RF, Sigurdsson MI, Palsson R. Rate of SARS-CoV-2 reinfection during an Omicron wave in Iceland. JAMA Netw Open. 2022;5(8):e2225320.","journal-title":"JAMA Netw Open"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02819-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:04:17Z","timestamp":1786705457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02819-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02819-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8489939\/v1","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"<b><i>Conflict of interest<\/i><\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Heinrich-Heine-University D\u00fcsseldorf\u2019s Ethics Committee, as the leading ethics committee, approved the study protocol, informed consent forms, and participant information materials in November 2021 (under the study registration number 2021\u20141688). In addition, the Ethics Committee at each clinical research site approved the study.","order":2,"name":"Ethics","label":"Ethical Approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participation in the study was voluntary and required comprehensive medical information about the meaning and purpose of the study, as well as the advantages and disadvantages of participating in the study and a signed declaration of consent. The study participant could revoke this consent in writing or verbally without giving reasons. In the event of a revocation, the study participant could decide whether the data collected for the study should be deleted, whether the samples obtained or the test results collected should be destroyed, or whether they can continue to be used for the study. The data and biomaterials collected during the study will be retained for a maximum of 10\u00a0years after completion of the study. The study participants had the opportunity to limit the use of data in the declaration of consent as part of the study information regarding other\/future research purposes and time.","order":3,"name":"Ethics","label":"Participant informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The coordinator center is the Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Medical Faculty of Heinrich Heine University D\u00fcsseldorf, Germany. Further centers are the Department of Pneumology and Intensive Care Medicine, RWTH University Hospital, Aachen, Germany; Department of Medicine I, University Hospital Bonn, Germany; Department of Infectious Diseases; West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital, University of Cologne, Germany; Department of Internal Medicine B, Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital M\u00fcnster, Germany.","order":5,"name":"Ethics","label":"Study centres","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered in the German Clinical Trials Register under the Clinical trial number DRKS00027377 on 08.12.2021, accessible online at:","order":6,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pseudonymized health data was collected by the study centers during each study visit on standardized case report forms (CRFs). This included demographic, clinical, and viro-immunological data. These health data were transferred into a clinical database system (Clincase, Quadratek Data Solutions Ltd., Berlin, Germany), administered by the Center for Clinical Studies Essen, Germany (ZKSE). Recording and health data transfer were subject to the consent of the study participants. Data collection procedures strictly adhere to the established protocol, the recent version of the Declaration of Helsinki, general data protection regulations of the European Union (EU-DSGVO), and the International Conference on Harmonization Good Clinical Practice (ICH-GCP). Data quality and plausibility checks were carried out by trained ZKSE employees. Complex plausibility checks were programmed in SAS. If necessary, queries were sent to members of the study teams at the centers to make corrections to the data.","order":7,"name":"Ethics","label":"Data collection","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The pseudonymously collected data is analyzed and evaluated for interim evaluations and finally for the legally required evaluations. All data in the study database can only be identified by a participant identification number (participant ID) corresponding to participant consent to ensure pseudonymization. The birth year is documented in the database, not the day and month. Only the local study centers maintain a separate confidential identification list to identify everyone enrolled to enable participants. This list is protected from unauthorized access stored in the respective study center. All persons who have access to pseudonymized data are subject to the general data protection regulations of the European Union (EU-DSGVO) when handling the data. Only anonymized data are passed on when the final study report is submitted to the responsible German authorities (higher federal authorities, ethics committees if applicable). Publications on the study will only be made with anonymous data. The data must be retained following legal requirements. An assessment of the necessity and proportionality of the data processing was obtained. A risk assessment regarding the possible risks caused by the processing for those affected is taken into account, and the protection goals of confidentiality, integrity, and availability were assessed. The remaining residual risk regarding the protection goals of integrity, legal control, availability, and confidentiality after implementation of technical and organizational measures are classified as low.","order":8,"name":"Ethics","label":"Data protection","group":{"name":"EthicsHeading","label":"Declarations"}}]}}